The Indian drug landscape presents a complex picture, increasingly characterized by worries surrounding monopolistic practices. While the country is lauded as a global pharmaceutical powerhouse and a crucial source of affordable medicines, a growing number of experts are highlighting the propensity for a few large firms to control significant marke

India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few leading players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of industry concentration that warrants scrutiny. These established companies, including entities